This article is more than 5 years old. Information may no longer be current.

J&J to distribute three Santen ophthalmic products

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

JACKSONVILLE, Fla. — Johnson & Johnson Vision Care Inc. said it has entered into a U.S. distribution and supply agreement for three prescription ophthalmic pharmaceutical agents from the Japan-based Santen Pharmaceutical Group. During the first quarter of 2004, J&J Vision Care will become the exclusive U.S. distributor for Quixin (levofloxacin), Betimol (timolol hemihydrate) and Alamast (pemirolast potassium). Santen will continue to have responsibility for manufacturing, clinical and regulatory activities associated with these products, according to a J&J press release. The financial terms of the agreement were not disclosed.